Literature DB >> 17401395

Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantation.

M Hakki1, A P Limaye, H W Kim, K A Kirby, L Corey, M Boeckh.   

Abstract

Limited data exist regarding the incidence and factors associated with outcome of invasive Pseudomonal infections in hematopoietic cell transplant (HCT). A retrospective analysis of cases of invasive Pseudomonas aeruginosa infection and factors associated with outcome was performed. P. aeruginosa invasive infection occurred in 95 of 5772 patients (1.65%) a median of 63 days after HCT (range 5-1435). Only 28% of infections occurred during periods of neutropenia (absolute neutrophil count<500 cells/mm(3)). Infection-attributable mortality during the initial episode of infection was 35.8%. Factors associated with initial mortality included the presence of a copathogen and high-dose steroid use. Ten (16.4%) of those who survived the initial infection experienced a recurrence of P. aeruginosa infection at a median of 9 days (range 3-17) after stopping antibiotics and 60% of those died as a result of recurrent infection a median of 1 day (range 1-7) after onset of recurrence. Grade 3-4 graft-versus-host disease was associated with a higher risk of recurrent infection. The risk of recurrence was not influenced by the presence of copathogens. Thus, invasive P. aeruginosa infections are associated with high recurrence rates and mortality in this immunocompromised population. Aggressive attempts to reduce immunosuppression and to treat copathogens may help during the initial infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17401395     DOI: 10.1038/sj.bmt.1705653

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  23 in total

1.  Transforming growth factor-β induces microRNA-29b to promote murine alveolar macrophage dysfunction after bone marrow transplantation.

Authors:  Racquel Domingo-Gonzalez; Carol A Wilke; Steven K Huang; Yasmina Laouar; Jeanette P Brown; Christine M Freeman; Jeffrey L Curtis; Gregory A Yanik; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-31       Impact factor: 5.464

Review 2.  Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator.

Authors:  Deepak Balasubramanian; Hansi Kumari; Kalai Mathee
Journal:  Pathog Dis       Date:  2015-02-26       Impact factor: 3.166

3.  Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients.

Authors:  M Mikulska; V Del Bono; P Bruzzi; A M Raiola; F Gualandi; M T Van Lint; A Bacigalupo; C Viscoli
Journal:  Infection       Date:  2011-12-21       Impact factor: 3.553

4.  Ceftolozane-tazobactam therapy for multidrug-resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies and hematopoietic-cell transplant recipients.

Authors:  Morgan Hakki; James S Lewis
Journal:  Infection       Date:  2018-02-19       Impact factor: 3.553

Review 5.  Delayed opportunistic infections in hematopoietic stem cell transplantation patients: a surmountable challenge.

Authors:  Kieren A Marr
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

6.  High-dose continuous infusion beta-lactam antibiotics for the treatment of resistant Pseudomonas aeruginosa infections in immunocompromised patients.

Authors:  Brad Moriyama; Stacey A Henning; Richard Childs; Steven M Holland; Victoria L Anderson; John C Morris; Wyndham H Wilson; George L Drusano; Thomas J Walsh
Journal:  Ann Pharmacother       Date:  2010-04-06       Impact factor: 3.154

7.  Incidence rate of fluoroquinolone-resistant gram-negative rod bacteremia among allogeneic hematopoietic cell transplantation patients during an era of levofloxacin prophylaxis.

Authors:  Arianna Miles-Jay; Susan Butler-Wu; Ali Rowhani-Rahbar; Steven A Pergam
Journal:  Biol Blood Marrow Transplant       Date:  2014-12-11       Impact factor: 5.742

8.  Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromes.

Authors:  Bart L Scott; J Y Park; H Joachim Deeg; Kieren A Marr; Michael Boeckh; Thomas R Chauncey; Frederick R Appelbaum; Rainer Storb; Barry E Storer
Journal:  Biol Blood Marrow Transplant       Date:  2008-07       Impact factor: 5.742

Review 9.  Management of febrile neutropenia in the era of bacterial resistance.

Authors:  Sehnaz Alp; Murat Akova
Journal:  Ther Adv Infect Dis       Date:  2013-02

10.  Pseudomonas aeruginosa eliminates natural killer cells via phagocytosis-induced apoptosis.

Authors:  Jin Woong Chung; Zheng-Hao Piao; Suk Ran Yoon; Mi Sun Kim; Mira Jeong; Suk Hyung Lee; Jeong Ki Min; Jae Wha Kim; You-Hee Cho; Jin Chul Kim; Jeong Keun Ahn; Kyoon Eon Kim; Inpyo Choi
Journal:  PLoS Pathog       Date:  2009-08-28       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.